SIR -Reduced funding and increased competition among a larger body of active researchers also affects countries other than the United States, and fields other than the biomedical sciences.
Here in the United Kingdom, those of us who use the Engineering and Physical Sciences Research Council (EPSRC) for funding have witnessed a similar scenario to that described in your News Feature: a smaller fraction of assessed grants are being funded and we have reached the stage where there is -for all practical purposes -a lottery to determine which of the many excellent proposals submitted will be successful.
The amount of money that is available for curiosity-driven research is also decreasing, as the government seeks to steer funding into areas of political priority. The response from the scientific community is, of course, to become more inventive about the potential applications of a given proposal.
I believe that the best way to maintain research activity is through diversity in both sources of funding and topic. You indicate that undue weight is given to National Institutes of Health funding (as opposed to general funding) in many US institutions as a requirement for tenure or promotion. This may further concentrate academics in attempting to access a finite pot, with a consequently reduced rate of success.
However, despite the disappointment that we may feel in not receiving enough funding to maintain our activity or research-group size at a desired level, we academics should recognize our privileged tenured position in times of economic hardship such as the present. Balancing the need for increased spending to further economic growth with the need to spend more effectively during this economic downturn means that we must improve our ability to decide what research is worth funding. Simply lowering the percentage of funded grants won't cause this to happen by itself.
Brian Derby
Effective spending depends on detailed peer review to assess applications properly. But the review quality necessary may be hard to realize in practice, because there is more and more research to review. The traditional rankings devised from impact factors don't take this kind of work into consideration -rather, they promote more writing, creating more work for reviewers. A better system would properly credit people for their review and assessment work so that money could be spent more effectively. Countries OECD, 2007) . Our biomedical fellowship scheme is backlogged to the point that the awards designed to support new principal investigators go mostly to well-established group leaders.
William Gunn
A recent survey of the medical research workforce in Australia highlights the level of anxiety and discontent over poor careerdevelopment opportunities and lack of funding (M. Kavallaris et al. Med. J. Australia 188, 520-524; 2008) . In the preceding five years, for example, 6% of respondents had already left active research; 73% were considering leaving. This presents a clear challenge for recruitment and retention of a highly skilled workforce.
To keep Australian science at the leading edge, we need to maintain the flow of fresh ideas by ensuring opportunities for both new and established investigators. The new US administration has recognized the loss of careerdevelopment opportunities caused by underfunding. Australia runs the risk of failing to capitalize on significant government investments made so far. The recent announcement of a federal fellowship scheme for mid-career researchers hints at a potential improvement. But the near-term prospects for aspiring new investigators and those returning from overseas are not promising. 
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